|
Words of Welcome Board & Organiz
|
 |
Programme-at-a-glance
| |
SUNDAY, 3 SEPTEMBER 2006 |
| |
Auditorium |
Ballroom West |
Ballroom East |
Room
1.61 - 1.64 |
Room
1.41 - 1.44 |
Exhibition / Poster area |
| 08:30 - 10:00 |
|
E1 - Progenitor Cells |
E2 - Transfusion in Resource Limited Countries |
|
|
|
| 10:30 - 12:00 |
|
E3 - Evidence Based
Transfusion Medicine |
E4 - Transfusion in
Resource Limited Countries |
|
|
|
| 12:15 - 13:45 |
|
|
|
Satellite Symposium
OCD |
Satellite Symposium
Pall Medical |
|
| 14:00 - 15:30 |
|
E5 - Advances in Haemostasis |
E6 - Transfusion in Resource Limited Countries |
|
|
|
| 16:00 - 17:30 |
|
E7 - New Frontiers in Blood Transfusion |
E8 - Paediatric
Transfusion
Practice |
|
|
|
| 17:45 - 18:45 |
Opening Ceremony |
|
|
|
|
|
| 18:45 - 20:45 |
|
|
|
|
|
Opening of the Trade Exhibition / Welcome Cocktail Party |
| |
|
| |
MONDAY 4, SEPTEMBER 2006 |
| |
Auditorium |
Ballroom West |
Ballroom East |
Room
1.61 - 1.64 |
Room
1.41 - 1.44 |
Exhibition / Poster area |
| 08:30 - 10:00 |
P1 - Transmissible Spongiform Encephalopathies |
|
|
|
|
|
| 10:30 - 12:00 |
S3 - Donor Management-Developing a Donor Program |
S1 - Quality
Management in BT |
S5 - Bacterial
Contamination of
Blood Products |
S2 - Paediatric
Transfusion Practice |
S4 - Plasma
Derivatives in
Clinical Practice |
|
| 12:15 - 13:45 |
|
Satellite Symposium
Gambro |
Symposium
ISBT Working
Party on TTD |
|
|
|
| 14.00 - 15.30 |
S9 - Structure and
Governance of BTS |
S6 - Leucocyte
Depletion |
S7 - Auto-transfusion |
S10 - Cellular
Therapies |
S8 - National
Blood Inventory
Management |
|
| 16.00 - 17.30 |
S15 - Red Cell
Immunohaematology |
S11 -
Hepatitis |
S12 - NATA
Symposium:
The Anaemia of
Chronic Disease |
S14 - Non-infectious
Hazards of
Transfusion |
S13 - Platelet and
Megakaryocyte
Immunology |
|
| 17.30 - 18.30 |
|
|
|
|
|
Poster Walk 1 (snacks and drinks) |
| |
|
| |
TUESDAY, 5 SEPTEMBER 2006 |
| |
Auditorium |
Ballroom West |
Ballroom East |
Room
1.61 - 1.64 |
Room
1.41 - 1.44 |
Exhibition / Poster area |
| 08:30 - 09:30 |
P2 - ISBT Award
Lectures |
|
|
|
|
|
| 10:00 - 11:30 |
P3 - ISBT Presidential
Award Symposium |
|
|
|
|
|
| 11:45 - 13:00 |
ISBT
General Assembly |
|
|
|
|
|
| 13.15 - 14.45 |
|
|
Satellite Symposium
Chiron |
Satellite Symposium
Octapharma |
Satellite Symposium
Cerus |
|
| - 15.15 |
|
|
|
|
|
| 15.00 - 19.00 |
General Excursion to Chapman’s Peak |
| |
|
| |
WEDNESDAY, 6 SEPTEMBER 2006 |
| |
Auditorium |
Ballroom West |
Ballroom East |
Room
1.61 - 1.64 |
Room
1.41 - 1.44 |
Exhibition / Poster area |
| 08.30 - 10.00 |
P4 - Ethical Issues in
Blood Transfusion
Practice |
|
|
|
|
|
| 10.30 - 12.00 |
S19 - Donor
Management |
S17 - Immune
Haemolytic
Anaemias |
S20 - Transfusion
Transmitted
Diseases (TTD) |
S18 - IPFA
Symposium |
S16 - Evidence
Based Transfusion
Medicine |
|
| 12.15 - 13.45 |
|
Satellite Symposium
BioRad |
|
|
Satellite Symposium
Roche Molecular
Systems |
|
| 14.00 - 15.30 |
S23 - HIV |
S21 - Haemostasis |
S25 - Donor
Management |
S22 - Artificial
O2 Carriers: Status
in 2006 |
S24 - Update of
BTS/Practice
in Africa |
|
| 16.00 - 17.30 |
S28 - Nucleic Acid
Amplification
Testing (NAT) |
S26 - Role of
International
Organisations in
Strengthening
/Supporting BTS |
S29 - Haemovigilance
Systems |
S30 - Rare Donor
Programme |
S27 - Resuscitation
/Massive Transfusion |
|
| 17.30 - 18.30 |
|
|
|
|
|
Poster Session 2
(snacks and drinks) |
| 19.00 - 24.00 |
African Theme Evening |
| |
|
| |
THURSDAY 7, SEPTEMBER 2006 |
| |
Auditorium |
Ballroom West |
Ballroom East |
Room
1.61 - 1.64 |
Room
1.41 - 1.44 |
Exhibition / Poster area |
| 08.30 - 10.00 |
S31 - Promoting
Blood Donation -
Art, Science or
Guesswork? |
S33 - Haemopoietic
Stem Cells |
S34 - Pathogen
Reduction /
Inactivation |
S32 - RBC Antigen
Modification |
S35 - Automation
and Data Processing
in BT |
|
| 10.30 - 12.00 |
S37 - West Nile
Virus and other
Emerging Pathogens |
S39 - Emerging
Technologies |
S36 - Thrombotic
Thrombocytopaenic
Purpura (TTP) |
S40 - History of
Blood Transfusion |
S38 - Quality
Management
in BT |
|
| 12.15 - 13.15 |
Closing Ceremony |
|
|
|
|
|
Preliminary Scientific Programme
| Saturday 2 september 2006 |
| PRE CONGRESS DAY |
| 17.00 - 19.00 |
Room: 1.41 - 1.42 |
| Blood Transfusion update in Eastern Mediterranean
Region |
| Chair: F. Moftah, Egypt |
| 17.00 - 17.05 |
| Introduction |
| F. Moftah (National Blood Transfusion Service, Giza, Egypt) |
| 17.05 - 17.30 |
| Plasma as a source material for fractionation |
| · Specificities of plasma for fractionation with
recommendation |
| A. Padilla (WHO, Geneve, Switzerland) |
| · Development of plasma contract fractionation protocol |
| T. Burnouf (Human Plasma Product Services, Lille,
France) |
| 17.30 – 17.45 |
| VIRAL INACTIVATION OF BLOOD COMPONENTS IN BLOOD CENTERS |
| M. El-Ekiaby (Red Crescent Society, Cairo, Egypt) |
| 17.45 – 18.00 |
| NEW APPROACH FOR BTS MANAGEMENT IN EGYPT, MODEL FOR EMR |
| F. Moftah (National Blood Transfusion Service,
Giza, Egypt) |
| 18.00 – 18.15 |
| UPDATE ON TRANSFUSION PRACTICES IN SAUDI ARABIA |
| S. Hindawi (National Blood Transfusion Service,
Jeddah, Saudi Arabia) |
| 18.15 – 18.30 |
| UPDATE ON WBDD 2006 ACTIVITIES |
| N. Dhingra (WHO, Geneva, Switserland) |
| 18.30 – 19.00 |
| ROUND TABLE DISCUSSION |
| All participants |
| |
|
| Sunday 3 september 2006 |
| EDUCATIONAL AND STATE OF THE ART REVIEWS |
| 08.30 - 10.00 |
Ballroom West |
| E1: Progenitor Cells |
| Chair: R.L. Crookes |
| 08.30 - 09.15 |
| 1ED-01-01 STEM CELL PLASTICITY |
| M. Pepper (Netcare Molecular Medicine Institute, Pretoria, South Africa) |
| 09.15 - 10.00 |
| 1ED-01-02 HAEMOPOIETIC STEM CELL THERAPY |
| J. Kurtzberg (Duke University Medical Center, Durham, United States of
America) |
| |
| 08.30 - 10.00 |
Ballroom East |
| E2: Transfusion in Resource Limited Countries |
| Chair: D. Mvere |
| 08.30 - 09.15 |
| 1ED-02-01 HOW TO ESTABLISH A NATIONAL BLOOD POLICY AND NATIONAL BLOOD PROGRAMME |
| N. Dhingra (WHO, Geneva, Switzerland) |
| 09.15 - 10.00 |
| 1ED-02-02 PRINCIPLES OF ESTABLISHING A VOLUNTARY DONOR BASE |
| C.K. Lin (Hong Kong Red Cross Blood Transfusion Service, Hong Kong, China) |
| |
| 10.00 – 10.30 |
| COFFEE BREAK |
| |
| 10.30 - 12.00 |
Ballroom West |
| E3: Evidence Based Transfusion Medicine |
| Chair: V. Poovalingam |
| 10.30 - 11.15 |
| 1ED-03-01 WHY DO WE BELIEVE IN BLOOD COMPONENT THERAPY? |
| B. McClelland (Scottish National Blood Transfusion Service, Edinburgh,
United Kingdom) |
| 11.15 - 12.00 |
| 1ED-03-02 TRANSFUSION ASSOCIATED GRAFT VS. HOST DISEASE |
| P.V. Holland (University of California, Davis Medical Center, Sacramento,United States of America) |
| |
| 10.30 - 12.00 |
Ballroom East |
| E4: Transfusion in Resource Limited Countries |
| Chair: G.M. Thurtell |
| 10.30 - 11.15 |
| 1ED-04-01 TESTING STRATEGIES |
| J.P. Allain (University of Cambridge, Cambridge, United Kingdom) |
| 11.15 - 12.00 |
| 1ED-04-02 PRACTICAL PROBLEM SOLVING IN BLOOD BANKS |
| A. Devenish (National Blood Service, London, United Kingdom) |
| |
| 12.00 – 14.00 |
| LUNCH BREAK AND SATELLITE SYMPOSIA |
| |
| SATELLITE SYMPOSIA |
12.15 – 13.45
Satellite Symposium organised by OCD |
Room 1.61 – 1.64 |
Global Automation and Process Excellence ....
Today, Tomorrow and the Future |
| This event will highlight the benefits of full automation in the area of
donor validation testing and patient pre-transfusion testing. It will also include customer
presentations on ORTHO AutoVue® Innova and the new donor screening platform, the ORTHO Paradigm®,
as well as a virtual reality tour through the donor screening laboratory of the future. |
| AUTOMATION IN THE TRANSFUSION LABORATORY:10 YEAR EXPERIENCE |
| J. Wallis (Freeman Hospital- Newcastle upon Tyne, United Kingdom) |
| A MULTICENTRIC STUDY ON SECOND LEVEL AUTOMATION IN IMMUNOHEMATOLOGY |
| M. Ripamonti (HTS Santa Chiara - Trento, Italy) |
| THE DONOR CENTRE PERSPECTIVE |
| K. Grundon (Automation Lead Engineer Ortho-Clincal Diagnostics) |
12.15 – 13.45
Satellite Symposium organised by Pall Medical |
Room 1.41 – 1.44 |
| Prions in Transfusion Medicine |
| Chair: A. Ross, Pall Corporation, USA |
| VCJD AND BLOOD TRANSFUSION - INCIDENCE AND RISKS |
| M. Turner (Scottish National Blood Transfusion Service, United Kingdom) |
| PRION REDUCTION - THE FRENCH APPROACH |
| J. Coste (Etablissements Français du Sanguine, Montpellier, France) |
| FROM LEUKOCYTE DEPLETION TO PRION REDUCTION -
EVOLVING STEPS TO INCREASE BLOOD SAFETY |
| J. Ortalano (Pall Corporation, United States of
America) |
| |
| EDUCATIONAL AND STATE OF THE ART REVIEWS |
| 14.00 - 15.30 |
Ballroom West |
| E5: Advances in Haemostasis |
| Chair: A.R. Bird |
| 14.00 - 14.45 |
| 1ED-05-01 RECENT ADVANCES IN THE BIOLOGY OF HAEMOSTASIS |
| E. Tuddenham (Royal Free Hospital, London, United Kingdom) |
| 14.45 - 15.30 |
| 1ED-05-02 ADVANCES IN THE THERAPY OF HAEMOSTATIC DISORDERS |
| P. Giangrande (Chuchill Hospital, Oxford, United Kingdom) |
| |
| 14.00 - 15.30 |
Ballroom East |
| E6: Transfusion in Resource Limited Countries |
| Chair: J. Emmanuel |
| 14.00 - 14.45 |
| 1ED-06-01 OVERALL STRATEGY FOR BLOOD SAFETY AND AVAILABILITY |
| K. Boukef (Centre Nat. De Transf. Sanguine, Tunis, Tunisia) |
| 14.45 - 15.30 |
| 1ED-06-02 APPROPRIATE CLINICAL USE OF BLOOD
IN CHILDREN IN RESOURCE CONSTRAINED SETTINGS |
| E. Molyneux (Queen Elizabeth Central Hospital, Blantyre, Malawi) |
| |
| 15.30 – 16.00 |
| TEA BREAK |
| |
| 16.00 - 17.30 |
Ballroom West |
| E7: New Frontiers in Blood Transfusion |
| Chair: R. Reddy |
| 16.00 - 16.45 |
| 1ED-07-01 MICROARRAYS AND BEYOND |
| R. Eglin (National Blood Service, London, United Kingdom) |
| 16.45 - 17.30 |
| 1ED-E7-02 STRUCTURE AND FUNCTION OF RED CELL SURFACE ANTIGENS |
| G. Daniels (National Blood Service, Bristol, United Kingdom) |
| |
| 16.00 - 17.30 |
Ballroom East |
| E8: Paediatric Transfusion Practice |
| Chair: G. Bellairs |
| 16.00 - 16.45 |
| 1ED-08-01 PATHOGENETIC MECHANISMS OF THE ANEMIA OF PREMATURITY |
| R. Strauss (University of Iowa College of Medicine, Iowa City, United States
of America) |
| 16.45 - 17.30 |
| 1ED-08-02 RBC TRANSFUSION AND/OR RECOMBINANT EPO THERAPY |
| OF THE ANEMIA OF PREMATURITY |
| R. Strauss (University of Iowa College of Medicine, Iowa City, United States
of America) |
| |
| 17.45 - 18.45 |
Auditorium |
| OPENING CEREMONY |
| |
| 18.45 – 20.45 |
Exhibition Area |
| WELCOME RECEPTION |
| |
|
| Monday 4 september 2006 |
| |
| PLENARY LECTURES |
| 08.30 - 10.00 |
Auditorium |
| PLENARY LECTURES 1: Transmissible Spongiform Encephalopathies (TSEs) |
| Chairs: S. Takamoto, A. Heyns |
| 08.30 - 09.15 |
| 2PL-01-01 HUMAN PRION DISEASES: BIOLOGY AND TRANSMISSION BY BLOOD |
| J. Ironside (University of Edinburgh, Edinburgh, United Kingdom) |
| 09.15 - 10.00 |
| 2PL-01-02
CONTROLLING THE BLOOD-BORNE SPREAD OF HUMAN PRION DISEASE |
| C.V. Prowse (SNBTS, Edinburgh, United Kingdom) |
| |
| 10.00 – 10.30 |
| COFFEE BREAK |
| |
| PARALLEL SESSIONS |
| 10.30 - 12.00 |
Ballroom West |
| S1: Quality Management in Blood Transfusion |
| Chairs: P.J. Coghlan, Y.M. Zhu |
| 10.30 - 11.00 |
| 2PS-01-01 GLOBALISATION AND BLOOD SAFETY |
| A. Farrugia (Therapeutic Goods Administration, Wooden, Australia) |
| 11.00 - 11.15 |
| 2PS-01-02VIRAL RISKS OF PLASMA-DERIVED MEDICINAL PRODUCTS |
| C.L. van der Poel, M.P. Janssen, B.A. van Hout, J. Over, H.T.M. Cuijpers
(UMC Utrecht, Utrecht, Netherlands) |
| 11.15 - 11.30 |
| 2PS-01-03
EU-Q-BLOOD-SOP: DEVELOPMENT OF PAN EUROPEAN QUALITY MANAGEMENT IN TRANSFUSION MEDICINE |
| C. Seidl, R. Henschler, E. Schellenberg, A. McMillan Douglas, C. Smit
Sibinga, M. Gorham, M. Letowska, J. de Wit, E. Seifried (Institute for Transfusion Medicine,
Frankfurt Am Main, Germany) |
| 11.30 - 11.45 |
| 2PS-01-04
LOT RELEASE OF MICROBIOLOGY BLOOD SCREENING KITS AND HCV NAT IN THE ENGLISH NATIONAL BLOOD SERVICE |
| J.A. Newham, A.D. Kitchen (NBS, London, United Kingdom) |
| 11.45 - 12.00 |
| 2PS-01-05
GUIDELINES FOR JUDICIOUS USE
OF BLOOD PRODUCTS: IMPLEMENTATION AND AUDIT. SIX YEARS EXPERIENCE AT A
TERTIARY-CARE CENTER IN ISRAEL |
| M. Hareuveni, B.O. Ben-Tal (TASMC, Tel Aviv, Israel) |
| |
| 10.30 - 12.00 |
Room: 1.61 - 1.64 |
| S2: Paediatric Transfusion Practice |
| Chairs: A.R. Bird, A. Brand |
| 10.30 - 10.55 |
| 2PS-02-01 THE IMPACT OF KANGAROO MOTHER CARE ON THE PREVALENCE OF BLOOD PRODUCT TRANSFUSIONS IN INFANTS <1800G MANAGED IN A DEVELOPING COUNTRY |
| G. Kirsten, H. Weyers (University of Stellenbosch, Tygerberg, South Africa) |
| 10.55 - 11.20 |
| 2PS-02-02 CLINICAL MANAGEMENT OF FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA |
| H. Kanhai (Leiden University Medical Center, Leiden, Netherlands) |
| 11.20 - 11.45 |
| 2PS-02-03 PLATELET TRANSFUSIONS TO INFANTS |
| R. Strauss (University of Iowa College of Medicine, Iowa City, United States
of America) |
| 11.45 - 12.00 |
| 2PS-02-04
SAFETY AND EFFICACY OF THERAPEUTIC EARLY-ONSET GRANULOCYTE TRANSFUSIONS IN PEDIATRIC PATIENTS WITH NEUTROPENIA AND SEVERE INFECTIONS |
| J.H. Sachs, A. Reiter, T. Walter, G. Bein, W. Woessmann (Justus Liebig
University Giessen, Giessen, Germany) |
| |
| 10.30 - 12.00 |
Auditorium |
| S3: Donor Management - Developing a Blood Donor Programme |
| Chairs: N. Dhingra, D. de Coning |
| 10.30 - 11.00 |
| 2PS-03-01
DONOR RIGHTS AND EXPECTATIONS |
| N. Mikkelsen (IFBDO/FIODS, Frederiksberg, Denmark) |
| 11.00 - 11.30 |
| 2PS-03-02 DEVELOPING A BLOOD DONOR PROGRAM MALAWI BLOOD TRANSFUSION SERVICE (MBTS) |
| J. Emmanuel (Malawi Blood Transfusion Service Project, Malawi) |
| 11.30 - 11.45 |
| 2PS-03-03
LEVERAGING DONOR LOYALTY FOR A STRONGER
GLOBAl BLOOD SUPPLY - ALLIANCE OF BLOOD OPERATOR PIAG (PERFORMANCE IMPROVEMENT ADVISORY GROUP) DONOR LOYALTY GROUP |
| F. Gogarty, J. Nugent, A. Harding, J. Granato, S. Pohlen (National Blood
Service, Herts, United Kingdom) |
| 11.45 - 12.00 |
| 2PS-03-04
THE ESTABLISHMENT OF HLA PHENOTYPE DATA BANK FOR BLOOD DONORS TO REDUCE NON-HEMOLYTIC TRANSFUSION REACTION AND PLATELET INFUSION INEFFICACY |
| Q. Wu, M.L. Liu, J. Qi (Shaanxi Blood Center, Xi`an, China) |
| |
| 10.30 - 12.00 |
Room: 1.41 - 1.44 |
| S4: Plasma Derivatives in Clinical Practice |
| Chairs : C. Rochat, H. Chapel |
| 10.30 - 11.00 |
| 2PS-04-01 IV IMMUNOGLOBULINS IN CLINICAL PRACTICE |
| H. Chapel (Oxford Radcliffe Hospital, Oxford, United Kingdom) |
| 11.00 - 11.15 |
| 2PS-04-02
CHARACTERIZATION OF THE SERUM AUTOANTIGENS RECOGNIZED BY INTRAVENOUS IMMUNOGLOBULINS (IVIg) USING 2D-PAGE AND LC-MS |
| R. Lemieux, R. Bazin, A. Laroche, C. Philippeau, T. Tremblay (Hema-Québec,
Sainte-foy, Québec, Canada) |
| 11.15 - 11.45 |
| 2PS-04-03 VOLUME EXPANDERS: CRYSTALLOIDS VS. PLASMA COLLOIDS VS. SYNTHETIC COLLOIDS |
| M. James (Groote Schuur Hospital, Cape Town, South Africa) |
| 11.45 - 12.00 |
| 2PS-04-04
FIBRIN GLUE PREPARED FROM SINGLE DONOR ALLOGENOUS PLASMA |
| M.J. Dijkstra-Tiekstra, C.J. van Delden, J. de Wildt-Eggen, W. Kuipers, A.
Setroikromo, W.M. Smid, M.M.W. Koopman, D. de Korte (Sanquin Blood Bank North East
Region, Groningen, Netherlands) |
| |
| 10.30 - 12.00 |
Ballroom East |
| S5: Bacterial Contamination of Blood Products |
| Chairs: M. Blajchman, J.P. Aubuchon |
| 10.30 - 11.00 |
| 2PS-05-01 THE RELIABILITY OF BACTERIAL DETECTION IN PLATELETS |
| J.P. Aubuchon (Dartmouth - Hitchcock Medical Centre, Lebanon, United States
of America) |
| 11.00 - 11.15 |
| 2PS-05-02
HEMA-QUEBEC'S EXPERIENCE WITH BACTERIAL CULTURE OF WHOLE-BLOOD DERIVED PLATELET CONCENTRATES (WBDPC) |
| G. Delage, P. Robillard, F. Bernier, M. Tremblay, J. Dion (Hema-Quebec,
St-Laurent, Canada) |
| 11.15 - 11.30 |
| 2PS-05-03
RESIDUAL RISK OF SEPTIC TRANSFUSION REACTIONS FROM BACTERIAL-TESTED APHERESIS PLATELETS |
| C.T. Fang, F. Eder, P. Notari, R.Y. Dodd, R.J. Benjamin (American Red Cross,
Rockville, Maryland, United States of America) |
| 11.30 - 11.45 |
| 2PS-05-04
THE IMPORTANCE OF THE SAMPLING TIME AFTER THE PREPARATION OF PLATELET CONCENTRATES FOR THE DETECTION OF BACTERIAL CONTAMINATION |
| E. Dickmeiss, M. Bidstrup, J. Salado (Rigshospitalet, Copenhagen, Denmark) |
| 11.45 - 12.00 |
| 2PS-05-05
COMPARISON OF THREE BACTERIAL DETECTION METHODS UNDER ROUTINE CONDITIONS |
| M.S. Schmidt, A. Karakassopoulos, J. Burkhart, R. Deitenbeck, J. Asmus, T.H.
Mueller, F. Weinauer, E. Seifried, G. Walther-Wenke (German Red Cross Institute
Frankfurt, Frankfurt, Germany) |
| |
| 12.00 – 14.00 |
| LUNCH BREAK, VISIT TO THE EXHIBITION AND POSTERS AND SATELLITE SYMPOSIA |
| |
| SATELLITE SYMPOSIUM |
12.15 – 13.45
Satellite Symposium organised by Gambro  |
Ballroom West |
| NEW IDEAS… NEW ENERGY |
| (From one of the world’s foremost renaissance
thinkers at the Gambro BCT satellite symposium) |
| HOW TO THINK LIKE LEONARDO DA VINCI |
Seven steps to genius every day. Experience in the
energy and intelligence of innovation and creativity, expert ichael J. Gelb
(www.bigspeak.com). His entertaining seminar will teach you to:
balance analysis and imagination; cultivate an innovative working environment;
sustain continuous learning) |
| ISBT WORKING PARTY SYMPOSIUM |
12.15 – 13.45
Symposium organised by ISBT Working Party on
Transfusion Transmissible
Diseases |
Ballroom East |
| Global experience with nucleic acid amplification (NAT) systems for blood donor screening |
| Chairs: S. Wendel, K. Roth, M. Busch, J-P. Allain |
| Part 1: Comparison of performance between two
commercial IV/HCV/HBV NAT systems |
| 12.00 – 12.10 |
| P-128 COMPARISON OF THE CHIRON PROCLEIX® TIGRIS®
AND OCHE COBAS S 201 NUCLEIC ACID TESTING (NAT) SYSTEMS FOR SIMULTANEOUS
DETECTION OF HIV/HCV RNA AND HBV DNA * |
| C.K. Lin, A.R. Margaritis, S. Brown, C.R. Seed, P.
Kiely, B. D'Agostino, A.J. Keller (Australian Red Cross Blood Service, Perth,
Australia) |
| 12.10 – 12.20 |
| P-108 HEAD TO HEAD COMPARISON OF TWO NEW AUTOMATED
NAT SYSTEMS CHIRON: PROCLEIX TIGRIS SYSTEM VS ROCHE COBAS S 201 * |
| A. Assal, V. Barlet, C. Cornillot, M. Deschazeaux,
I. Dupont, P. Gallian, C. Guitton, P. Morel, G. Andreu (EFS Centre Atlantique,
Tours, France) |
| 12.20 – 12.30 |
| DISCUSSION |
| M.P. Busch (Blood Systems Research Institute, San
Francisco, United States of America) |
| Part 2: Feasibility and clinical yield of NAT in high prevalence areas |
| 12.30 – 12.40 |
| P-110 SEROLOGICAL AND MOLECULAR CHARACTERISTICS OF
HBV DNA POSITIVE/ HBSAG NEGATIVE BLOOD DONORS * |
| E. Brojer, M. Letowska, G. Liszewski, P.
Grabarczyk, M. Mikulska (Institute of Haematology and Blood Transfusion, Warsaw,
Poland) |
| 12.40 – 12.50 |
| P-018 DETECTION OF HIV-1 INFECTION IN BLOOD DONORS
DURING THE IMMUNOLOGICAL WINDOW PERIOD BY IMPLEMENTATION OF NUCLEIC ACID
AMPLIFICATION TECHNOLOGY * |
| P.S.P. Scuracchio, A.G. Oliveira Filho, M.M.M.
Lemos, M.C.C. Poli, R. Colella, M.M.C. Magri, N.J.F. Cavalcanti, E.C. Sabino,
N.A. Salles, D.A.F. Chamone (Banco de Sangue de São Paulo, São Paulo, Brazil) |
| 12.50 – 13.00 |
| P-136 EVALUATION OF ACCEPTED BLOOD DONORS WITH A
MULTIPLEX NUCLEIC ACID TEST (NAT) AT CHIANG MAI UNIVERSITY HOSPITAL, THAILAND * |
| L.T. Thaikruea, N.N. Niwes, S.T. Thongsawat, L.N.
Litrakoon, L.F. Fonksatidkil, P.S. Sompan, A.H. Heaton, D.N. Nichols, K.N.
Nelson (Department of Community Medicine, Chiang Mai, Thailand) |
| 13.00 – 13.10 |
| P-106 IMPLEMENTATION OF A POST-DONATION TRIPLEX
HIV/HCV/HBV NAT IN A TEACHING HOSPITAL TRANSFUSION MEDICINE UNIT IN KUMASI,
GHANA * |
| S. Owusu-Ofori, G. Bedu-Addo, D. Candotti, A.
Nsiah-Asare, F. Sarkodie, J-P Allain (Komfo Anokye Teaching Hospital, Kumasi,
Ghana) |
| 13.10 – 13.30 |
| DISCUSSION |
J-P Allain (University of Cambridge, Cambridge,
United Kingdom)
* Abstracts to be found in the poster section |
| |
| PARALLEL SESSIONS |
| 14.00 - 15.30 |
Ballroom West |
| S6: Leucocyte Depletion |
| Chairs: A.R. Bird, M. James |
| 14.00 - 14.40 |
| 2PS-06-01 UNIVERSAL LEUCOCYTE DEPLETION: PRO |
| M. Blajchmann (McMaster University, Hamilton, Canada) |
| 14.40 - 15.20 |
| 2PS-06-02 UNIVERSAL LEUCOCYTE DEPLETION: CON |
| E.C. Vamvakas (University of Ottawa, Ottawa, Canada) |
| 15.20 - 15.30 |
| DISCUSSION TIME |
| |
| 14.00 - 15.30 |
Ballroom East |
| S7: Auto-Transfusion |
| Chairs: M.H. Sayers, L.T. Goodnough |
| 14.00 - 14.45 |
| 2PS-07-01 PREDEPOSIT AUTOLOGOUS DONATIONS |
| L.T. Goodnough (Stanford University Medical Center, Stanford, United States
of America) |
| 14.45 - 15.00 |
| 2PS-07-02
PREOPERATIVE AUTOLOGOUS BLOOD DONATION CAUSES IMMUNOMODULATION IN PATIENTS UNDERGOING ELECTIVE HIP REPLACEMENT SURGERY |
| R. Karger, C. Weber, J. Schmidt, V. Kretschmer (Philipps University Marburg,
Marburg, Germany) |
| 15.00 - 15.15 |
| 2PS-07-03
TEN YEARS EXPERIENCE WITH BLOOD SALVAGE IN CANCER SURGERY AND ITS EFFECT ON OUTCOME |
| E.N. Hansen, G. Roth, V. Bechmann, M.T. Pawlik (University of Regensburg,
Regensburg, Germany) |
| 15.15 - 15.30 |
| 2PS-07-04
PREOPERATIVE AUTOLOGOUS BLOOD DONATION IN 2005: EXPERIENCE OF A BLOOD CENTRE IN PARIS REGION. |
| G. Woimant, C. Fretz, M.M. Sterlin, D. Benomar, P. Anceau, E. Pelissier,
J.L. Beaumont, P. Bierling (EFS Ile de France, Paris, France) |
| |
| 14.00 - 15.30 |
Room: 1.41 - 1.44 |
| S8: National Blood Inventory Management |
| Chairs: R. Reddy, J.F. Chapman |
| 14.00 - 14.30 |
| 2PS-08-01 THE BENEFITS OF DATA COLLECTION FOR EFFECTIVE INVENTORY MANAGEMENT |
| J.F. Chapman (Blood Stocks Management Scheme, NBS, London, United Kingdom) |
| 14.30 - 15.00 |
| 2PS-08-02 CENTRALISED MANAGEMENT
OF THE BLOOD INVENTORY - FROM THE BLOOD CENTRE TO HOSPITALS |
| M. Koh (Health Sciences Authority, Singapore, Singapore) |
| 15.00 - 15.15 |
| 2PS-08-03
EXPERIENCES WITH FROZEN BLOOD PRODUCTS IN THE NETHERLANDS MILITARY |
| F. Noorman, C.C.M. Lelkens, J.G. Koning, B. de Kort, I.B.G. Floot (Military Bloodbank, Leiden, Netherlands) |
| 15.15 - 15.30 |
| 2PS-08-04 A NOVEL APPROACH TO OPTIMAL BLOOD PLATELETS LOGISTICS |
| C.Th. Smit Sibinga, N. van Dijk, R. Haijema, J. van der Wal (Academic
Institute IDTM, Groningen, Netherlands) |
| |
| 14.00 - 15.30 |
Auditorium |
| S9: Structure and Governance of Blood Transfusion Services |
| Chairs: M. Bayik, L. Mpuntsha |
| 14.00 - 14.20 |
| 2PS-09-01 CANADA |
| G. Sher (Canadian Blood Services, Ottawa, Canada) |
| 14.20 - 14.40 |
| 2PS-09-02 THE BLOOD SYSTEM IN QUÉBEC |
| F. Décary (Hema-Québec, Québec, Canada) |
| 14.40 - 15.00 |
| 2PS-09-03 ENGLAND: NATIONAL BLOOD SERVICE (NBS) |
| M. Gorham (NBS, London, United Kingdom) |
| 15.00 - 15.20 |
| 2PS-09-04
China:Providing ADEQUATE SAFE BLOOD TO 1.3 BILLION PEOPLE |
| Y.M. Zhu (Shanghai Blood Center, Shanghai, China) |
| 15.20 - 15.30 |
| DISCUSSION TIME |
| |
| 14.00 - 15.30 |
Room: 1.61 - 1.64 |
| S10: Cellular Therapies |
| Chairs: J. McCullough, N. Novitzky |
| 14.00 - 14.30 |
| 2PS-10-01 CELLULAR THERAPIES FOR MALIGNANT AND NON-MALIGNANT DISORDERS |
| z. Slavin (Cell Therapy & Transplantation Research, Jerusalem, Israel) |
| 14.30 - 15.00 |
| 2PS-10-02 STEM CELL THERAPY FOR MYOCARDIAL INFARCTION |
| E. Seifried (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| 15.00 - 15.15 |
| 2PS-10-03
THE IMMUNOMODULATORY AND CLINICAL EFFECT OF EXTRACORPOREAL PHOTOCHEMOTHERAPY IN PATIENTS WITH CHRONIC GVHD AND CTCL. THE ROLE OF DENDRITIC CELLS IN THE PROCEDURE |
| Z.G. Gasova, R.S. Spisek, L.D. Dolezalova, I.M. Marinov (Institute of
Hematology and Blood Transfusion, Prague, Czech Republic) |
| 15.15 - 15.30 |
| 2PS-10-04
EXTRACORPOREAL PHOTOCHEMOTHERAPY FOR ACUTE AND CHRONIC GVHD, A REPORT OF 75 PATIENTS TREATED IN A SINGLE INSTITUTION |
| E. Dann, A. Badian, T. Stravets, L. Kertsman, A. Olivan, L. Bonstein, J.M.
Rowe (Rambam Medical Center, Haifa, Israel) |
| |
| 15.30 – 16.00 |
| TEA BREAK |
| |
| 16.00 - 17.30 |
Ballroom West |
| S11: Hepatitis |
| Chairs: H. Alter, J.P. Allain |
| 16.00 - 16.25 |
| 2PS-11-01 EPIDEMIOLOGY OF HBV INFECTION AND HBV-RELATED HEPATOCELLULAR CARCINOMA IN AFRICA: NATURAL HISTORY AND CLINICAL OUTCOME |
| M. Kew (University of the Witwaterbrand and NHLS, Johannesburg, South
Africa) |
| 16.25 - 16.50 |
| 2PS-11-02 APPROACHES TO HEPATITIS SAFETY IN SUB - SAHARAN AFRICA |
| J.P. Allain (University of Cambridge, Cambridge, United Kingdom) |
| 16.50 - 17.15 |
| 2PS-11-03 ADVANCES IN THE TREATMENT OF HEPATITIS B AND C |
| R. Hift (Groote Schuur Hospital, Dept. of Medicine, Cape Town, South Africa) |
| 17.15 - 17.30 |
| 2PS-11-04
MORTALITY IN HEPATITIS C VIRUS (HCV) INFECTED BLOOD DONORS: A LARGE, RETROSPECTIVE COHORT STUDY |
| E.L. Murphy (Univ California San Francisco and BSRI, San Francisco, United
States of America) |
| |
| 16.00 - 17.30 |
Ballroom East |
| S12: NATA Symposium - The Anaemia of Chronic disease |
| Chairs: A. Maniatis, F. Décary |
| 16.00 - 16.30 |
| 2PS-12-01 HOW MANY RED CELL UNITS ARE NEEDED FOR A POPULATION? DATA FROM SCOTLAND 2002 |
| B. McClelland (Scottish National Blood Transfusion Service, Edinburgh,
United Kingdom) |
| 16.30 - 16.50 |
| 2PS-12-02 PATHOPHYSIOLOGY OF THE ANAEMIA OF CHRONIC DISEASE |
| L.T. Goodnough (Stanford University Medical Center, Stanford, United States
of America) |
| 16.50 - 17.10 |
| 2PS-12-03 CAN WE AVOID TRANSFUSION IN TREATING THE ANAEMIA OF INFLAMMATORY BOWEL DISEASE? |
| K. Erichsen (Childrens Clinic, Bergen, Norway) |
| 17.10 - 17.30 |
| 2PS-12-03 TREATING THE ANAEMIA OF CANCER |
| M. Auerbach (Baltimore, United States of America) |
| |
| 16.00 - 17.30 |
Room 1.41 - 1.44 |
| S13: Platelet and Megakaryocyte Immunology |
| Chairs: A. Heyns, C. Kaplan Gouet |
| 16.00 - 16.25 |
| 2PS-13-01 PLATELET IMMUNOLOGY, PRESENT AND FUTURE |
| W. Ouwehand (University of Cambridge, Cambridge, United Kingdom) |
| 16.25 - 16.50 |
| 2PS-13-02 PLATELET BIOLOGY: COLLAGEN ACTIVATION MECHANISMS AND THEIR RELEVANCE TO TRANSFUSION MEDICINE |
| P. Smethurst (National Bloodservice Cambridge Centre, Cambridge, United
Kingdom) |
| 16.50 - 17.15 |
| 2PS-13-03 HOW THE PLATELET ACTUALLY WORKS |
| F. de Groot (UMC, Thrombosis and Haemostasis Laboratory, Utrecht,
Netherlands) |
| 17.15 - 17.30 |
| 2PS-13-04
FEEDBACK ON THE 2006 PLATELET IMMUNOLOGY WORKSHOP |
| Z. Foxcroft (South African National Blood Service (SANBS), Roodepoort, South
Africa) |
| |
| 16.00 - 17.30 |
Room 1.61 - 1.64 |
| S14: Non-Infectious Hazards of Transfusion |
| Chairs: G. Bellairs, P.V. Holland |
| 16.00 - 16.30 |
|
2PS-14-01 TRANSFUSION-RELATED ACUTE LUNG INJURY AND TRANSFUSION-ASSOCIATED CIRCULATORY OVERLOAD |
|
P.V.
Holland
(University
of
California,
Davis
Medical
Center,
Sacramento,United
States
of
America) |
| 16.30 - 17.00 |
| 2PS-14-02 HAEMOLYTIC REACTIONS |
| M. Contreras (National Blood Service, London, United Kingdom) |
| 17.00 - 17.15 |
| 2PS-14-03
HAEMOVIGILANCE REPORTS OF POST-TRANSFUSION PURPURA AND TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE BEFORE AND AFTER IMPLEMENTATION OF UNIVERSAL LEUCOCYTE DEPLETION IN THE UK |
| L.M. Williamson, D. Stainsby, H. Jones, E. Love, C. Chapman, A. Casbard, H.
Cohen (University of Cambridge/NBS, Cambridge, United Kingdom) |
| 17.15 - 17.30 |
| 2PS-14-04
OUTCOME AMONG RECIPIENTS OF ABO NON-IDENTICAL BUT ABO COMPATIBLE PLASMA: A SWEDISH-DANISH REGISTER-BASED COHORT STUDY |
| A. Shanwell, K. Rostgaard-Petersen, M. Ahlgren, H. Hjalgrim, M. Reilly (Karolinska University Hospital, Stockholm, Sweden) |
| |
| 16.00 - 17.30 |
Auditorium |
| S15: Red Cell Immunohaemotology |
| Chairs: G. Daniels, E. Smart |
| 16.00 - 16.30 |
| 2PS-15-01 RECENT PROGRESS IN MOLECULAR UNDERSTANDING OF ABO&P-RELATED BLOOD GROUPS |
| M.L. Olsson (Lund University, Lund, Sweden) |
| 16.30 - 17.00 |
| 2PS-15-02 BLOOD GROUP MOLECULAR GENOTYPING |
| C.E. van der Schoot (Sanquin Research, Amsterdam, Netherlands) |
| 17.00 - 17.15 |
| 2PS-15-03
RHD GENE CARRIERS AMONG SEROLOGICALLY D NEGATIVE DONORS: ALLELES AND POPULATION FREQUENCY IN CENTRAL EUROPE |
| A. Flegel, I. Von Zabern, F. Wagner (IKT Ulm, Ulm, Germany) |
| 17.15 - 17.30 |
| 2PS-15-04
THE TRUE CHEMICAL BASIS OF THE A1 AND A2 PHENOTYPES |
| L. Svensson, L. Rydberg, S. Henry (Sahlgrenska University Hospital,
Gothenburg, Sweden) |
| |
| POSTER WALK 1 |
Poster-walks are going to be held for the first time this year. This new
event is introduced in order to gain a maximum benefit from the scientific work presented and to create a lively interaction between poster authors, moderators and
interested congress participants. Poster-walks will be organised during the poster
sessions on Monday, 4 September and on Wednesday, 6 September (17.30 – 18.30 hours).
The poster area is located next to the exhibtion.
Poster authors, moderators and interested congress participants are kindly
requested to be present at the first poster in their poster session at the
beginning of the presentation time (17.30 hours).
Snacks and drinks will be served. |
| |
THE FOLLOWING POSTERS WILL BE DISCUSSED ON MONDAY:
| Topic 01.1. |
Blood Safety - TTD - HIV |
P-001 – P-012 |
| Topic 01.2. |
Blood Safety - TTD - Hepatitis |
P-025 – P-055 |
| Topic 01.3. |
Blood Safety - TTD - TSEs |
P-086 – P-093 |
| Topic 01.4. |
Blood Safety - TTD - West Nile Virus |
P-086 – P-093 |
| Topic 01.5. |
Blood Safety - TTD - Emerging Pathogens |
P-100 – P-113 |
| Topic 01.7. |
Blood Safety - TTD - Bacterial
Contamination |
P-141 – P-149 |
| Topic 01.8. |
Blood Safety - TTD - Parasites |
P-160 – P-167 |
| Topic 02.1. |
Red Cells - Immunohaematology |
P-168 – P-231 |
| Topic 02.2. |
Red Cells - Immune
Haemolytic Aneamias |
P-284 – P-301 |
| Topic 02.3. |
Red Cells - Antigen
Modification |
P-302 – P-305 |
| Topic 02.4. |
Red Cells
Transfusion |
P-306 – P-326 |
| Topic 03.1. |
Haemostasis -
Recent Therapeutic
Advances |
P-349 – P-352 |
| Topic 03.3. |
Haemostasis
- TTP |
P-360 –
P-364 |
| Topic 04.1. |
Pathogen
Reduction/Inactivation
- Red Cells |
P-365 |
| Topic
04.2. |
Pathogen
Reduction/Inactivation
- Platelets |
P-366
– P-380 |
|
Topic
05.1. |
Donor
Management
-
Developing
Donor
Programs |
P-390
– P-402 |
|
Topic
05.2. |
Donor
Management
-
Recruiting
and
Managing
Donors
(incl
Management) |
P-413 – P-427 |
| Topic 06.1. |
Plasma Derivatives and Fractionation - Clinical Indications for Plasma Derivatives |
P-427 – P-441 |
| Topic 07.2. |
Clinical Transfusion Preactice - Massive
Transfusion/Resuscitation |
P-482 – P-485 |
| Topic 07.4. |
Clinical Transfusion Practice - Blood Substitutes |
P-493 – P-497 |
| Topic 08.1-3. |
Auto-Transfusion |
P-512 – P-522 |
| Topic 09.2. |
Stem Cells - Umbilical Cord Blood Stem Cells |
P-538 – P-546 |
| Topic 10.1. |
Platelet - Transfusion |
P-553 – P-568 |
| Topic 10.2. |
Platelet - Immunology |
P-585 – P-596 |
| Topic 11.1. |
Quality Management - Regulatory |
P-609 – P-617 |
| Topic 11.3. |
Quality Management Industry Perspective |
P-628 – P-639 |
| Topic 14.0. |
Transfusion in Resource Limited Countries |
P-682 – P-692 |
| Topic 15.0. |
Emerging Technologies |
1 P-705 – P-724 |
| Topic 16.0. |
Evidence Based Transfusion Medicine |
P-725 – P-737 |
| Topic 17.0. |
Other - History of Blood Transfusion |
P-738 – P-742 |
|
|
|
|
Tuesday 5 september 2006 |
| |
| PLENARY LECTURES |
| 08.30 - 09.30 |
Auditorium |
| PLENARY LECTURES 2: ISBT Award Lectures |
| Chairs: F. Décary (President of the ISBT), H.E.
Heier (Chairman of the Jean Julliard Prize Committee) |
| 08.30 - 09.00 |
3PL-02-01 JEAN JULLIARD PRIZE AWARD
LECTURE:
HIGH THROUGHPUT GENOTYPING FOR RED
CELL BLOOD GROUPS AND PLATELET ANTIGENS IN
TRANSFUSION MEDICINE |
| M. de Haas (Sanquin
Diagnostic Services, Amsterdam,
Netherlands) |
| 09.00 - 09.30 |
| 3PL-02-02
INTERNATIONAL WOMAN IN
TRANSFUSION AWARD
LECTURE: SELECTED LESSONS
LEARNED FROM BLOOD
GROUPS |
| M.E. Reid
(New York Blood
Center, New
York, United
States of
America) |
|
|
| 09.30 –
10.00 |
|
COFFEE
BREAK |
|
|
|
10.00 - 11.30 |
Auditorium |
| PLENARY LECTURES 3: ISBT Presidential Award Symposium: From Whole Blood to Blood Component Transfusion: Where Are We Now? |
| Chairs: F. Décary (President of the ISBT), W.G. van Aken (President of the Foundation Transfusion Medicine) |
| 10.00 - 10.05 |
| 3PL-03-01 INTRODUCTION |
| C.Th. Smit Sibinga (Member of the Foundation Transfusion Medicine) |
| 10.05 - 10.30 |
| 3PL-03-02 IMPROVEMENT IN PREPARATION TECHNIQUES FOR BLOOD COMPONENTS |
| R.N.I. Pietersz (Sanquin Blood Bank North West Region, Amsterdam, Netherlands) |
| 10.30 - 10.55 |
| 3PL-03-03 PLATELET TRANSFUSION: CURRENT STATUS OF QUALITY REQUIREMENTS AND STORAGE |
| P. Rebulla (Foundation IRCSS, Milan, Italy) |
| 10.55 - 11.20 |
| 3PL-03-04 WHAT QUALITY OF RED BLOOD CELLS SHALL WE OFFER THE TRANSFUSED PATIENT |
| C.F. Högman (Winner of the ISBT Presidential Award) |
| 11.20 - 11.30 |
| 3PL-03-05 PRESENTATION OF THE ISBT PRESIDENTIAL AWARD |
| F. Décary (President of the ISBT) |
| |
| 11.45 – 13.00 |
Auditorium |
| ISBT GENERAL ASSEMBLY |
| |
| SATELLITE SYMPOSIA |
13.15 – 14.45
Satellite Symposium organised by Cerus |
Room 1.41 – 1.44 |
| The INTERCEPT Blood System: solving today’s challenges in transfusion safety (Chikungunya virus, protozoa and bacteria) |
| Chairs: S. Wendel, E. Seifried |
| RISK OF TRANSFUSION-TRANSMITTED PARASITIC DISEASE – IS TESTING THE ONLY ANSWER TO TRANSFUSION SAFETY? |
| S. Wendel (Hospital Sírio Libanes, Sao Paulo, Brazil) |
| MANAGEMENT OF AN EMERGING PATHOGEN – IMPLEMENTATION OF THE INTERCEPT BLOOD SYSTEM IN FRANCE |
| J-P Cazenave (Etablissement Français du Sang - Alsace, Strasbourg, France) |
| BACTERIAL CONTAMINATION OF PLATELET COMPONENTS – TODAY’S SOLUTIONS |
| E. Seifried (German Red Cross Institute Frankfurt, Frankfurt, Germany) |
| THE INTERCEPT BLOOD SYSTEM – A HIGHER STANDARD IN BLOOD COMPONENT PROCESS CONTROL AND SAFETY |
| L. Corash (Cerus Corporation, Concord, United States of America) |
13.15 – 14.45
Satellite Symposium organised by Octapharma |
Room 1.61 – 1.64 |
| FFP or biopharmaceutical Plasma; A Real Therapeutic
Dilemma? |
| OCTAPLAS®: GMP MANUFACTURING - QUALITY AND SAFETY
STANDAARD |
| T-E Svae (Octapharma Pharmazeutika Produktions gmbH, Vienna, Austria) |
| FFP OR BIOPHARMACEUTICAL PLASMA: HOW TO DECIDE |
| P. Hellstern (City Hospital. Ludwigshafen, Germany) |
ADVERSE REACTIONS OF PLASMA TRANSFUSION;
A PARTICULAR CASE: TRALI |
| J.H. Sachs (Justus Liebig University Giessen, Giessen, Germany) |
| EXPERIENCES WITH UNIVERSAL BIOPHARMACEUTICAL PLASMA |
| C. Rochat (National Bioproducts Institute, Pinetown, South Africa) |
| SUMMARY |
| B.. Solheim (RiksHospitalet, Radium Hospitalet, Oslo, Norway) |
| QUESTIONS |
13:15 – 14.15
Satellite Symposium organised by Chiron |
Ballroom East |
| Impact of individual donation (ID) Nucleic Acid Testing on blood safety |
| 13.15 – 13.20 WELCOME AND OPENING |
A. Heaton (Chief Medical Officer, Chiron)
Introduction of Moderator: Arthur Bird MD. CEO, Western Province Blood Transfusion (WPBTS), Cape Town |
| 13.20 – 13.30 BLOOD SAFETY REASONS FOR NAT TESTING IN A SOUTH AFRICAN ENVIRONMENT |
| A. Heyns (South African National Blood Service, Johannesburg, South Africa) |
| 13.30 – 13.55 AUTOMATED INDIVIDUAL DONOR NAT TESTING AND ITS IMPLICATIONS FOR POST TRANSFUSION HIV TRANSMISSION RISK IN SOUTH AFRICA |
| R. Crookes (South African National Blood Service, Johannesburg, South Africa) |
| 13.55 – 14.20 5 YEARS OF NAT TESTING IN SINGAPORE: TRANSITION FROM SEMI-AUTOMATED HIV/HCV (DUPLEX) TESTING TO AUTOMATED HIV/HCV/HBV (TRIPLEX) TESTING ON
PROCLEIX ® TIGRIS ® SYSTEM |
| D. Teo (Health Sciences Authority, Singapore, Singapore) |
| 14.25 – 14.50 HBV WORLDWIDE: POLICY IMPLICATIONS OF NAT DIAGNOSIS AND EPIDEMIOLOGY |
| B. Carman (West Scotland Specialist Virology Center, Glasgow, Scotland, United Kingdom |
| 14.50 – 15.15 DISCUSSION ON IMPLICATIONS FOR INTERMEDIATE PREVALENCE COUNTRIES |
Moderator: Arthur Bird, Cape Town, South Africa
Panel speakers: Kap-No Lee (Korean Red Cross, Seoul, South-Korea), A. Hatzakis (National Retrovirus Reference Center, Athens, Greece) |
| 15.15 CLOSURE |
| |
15.00 GENERAL EXCURSION CHAPMANS PEAK TOUR.
FOR MORE INFORMATION SEE PAGE XXX |
| |
|
| Wednesday 6 september 2006 |
| PLENARY LECTURES |
| 08.30 - 09.30 |
Auditorium |
| PLENARY LECTURES 4: Ethical Issues in Blood
Transfusion Practice |
| Chairs: P.F.W. Strengers, C. Bianco |
| 08.30 - 09.15 |
| 4PL-04-01 GROUP RIGHTS VS. THE RIGHTS OF THE
INDIVIDUAL |
| S. Benatar (Groote Schuur Hospital, Dept. of
Medicine, Cape Town, South Africa) |
| 09.15 - 10.00 |
| 4PL-04-02 ETHICS OF STEM CELL COLLECTION, STORAGE
AND CLINICAL APPLICATION |
| A. Van Niekerk (University of Stellenbosch, South
Africa) |
| |
| 10.00 – 10.30 |
| COFFEE BREAK |
| |
| 10.30 - 12.00 |
Room: 1.41 - 1.44 |
| S16: Evidence Based Transfusion Medicine |
| Chairs: E.C. Vamvakas, W.G. van Aken |
| 10.30 - 11.00 |
| 4PS-16-01 NEW TRIALS TO GUIDE TRANSFUSION
PRACTICEWHAT'S NEW IN THE LAST 2 YEARS |
| B. McClelland (Scottish National Blood Transfusion
Service, Edinburgh, United Kingdom) |
| 11.00 - 11.30 |
| 4PS-16-02 EVIDENCE-BASED TRANSFUSION MEDICINE: TOP
TEN MISTAKES WHEN DOING CLINICAL RESEARCH – ARE YOU GUILTY? |
| N. Heddle (McMaster University, Hamilton, Canada) |
| 11.30 - 12.00 |
| 4PS-16-03 QUALITATIVE RESEARCH IN TRANSFUSION
MEDICINE: CLOSING THE GAP |
| S. Whittaker (McMaster University, Hamilton,
Canada) |
| |
| 10.30 - 12.00 |
Ballroom West |
| S17: The Immune Haemolytic Anaemias |
| Chairs : W. Mayr, M. Contreras |
| 10.30 - 10.50 |
| 4PS-17-01 PATHOGENESIS OF AUTOIMMUNE HAEMOLYTIC
ANAEMIAS(AIHA) |
| J. Semple (St Michael's Hospital, Toronto, Canada) |
| 10.50 - 11.10 |
| 4PS-17-02 TREATMENT OF AIHA |
| P. Ness (John Hopkins Medical Institution,
Baltimore, United States of America) |
| 11.10 - 11.30 |
| 4PS-17-03 LABORATORY APPROACH TO DIAGNOSIS AND
TRANSFUSION POLICY IN AIHA |
| M. de Haas (Sanquin, Diagnostics Services,
Amsterdam, Netherlands |
| 11.30 - 11.45 |
| 4PS-17-04
DOES A NEGATIVE DIRECT ANTIGLOBULIN TEST
EXCLUDE WARM AUTOIMMUNE HEMOLYTIC ANEMIA? A PROSPECTIVE STUDY OF 504
CASES |
| J.H. Sachs, S. Santoso, G. Bein (Justus Liebig
University Giessen, Giessen, Germany) |
| 11.45 - 12.00 |
| 4PS-17-05
EFFECT OF A SINGLE GIFT OF ANTENATAL
ANTI-D-PROPHYLAXIS WITH 1000 IU IN WEEK 30 ON THE INCIDENCE OF
RHESUS-D-IMMUNIZATION IN THE FIRST TRIMESTER OF NEXT PREGNANCY |
| J.M. Koelewijn, M. de Haas, T.G.M. Vrijkotte, G.J.
Bonsel, C.E. van der Schoot (Sanquin Research and Landsteiner Lab,
Amsterdam, Netherlands) |
| |
| 10.30 - 12.00 |
Room: 1.61 - 1.64 |
| S18: IPFA Symposium: Quality and safety of
plasma and plasma products |
| Chairs : T. Burnouf, A. Padilla |
| 10.30 - 10.50 |
| 4PS-18-01
PLASMA FRACTIONATION: PROGRESS AND
CURRENT ISSUES |
| T. Burnouf (Human Plasma Product Services, Lille,
France) |
| 10.50 - 11.10 |
| 4PS-18-02
THE IMPACT OF THE PLASMA MASTER FILE ON
BLOOD AND PLASMA COLLECTION ORGANIZATIONS |
| R. Buchel (PPTA Source / EPCC, Brussels, Belgium) |
| 11.10 - 11.30 |
| 4PS-18-03
WHO RECOMMENDATIONS ON THE PRODUCTION,
CONTROL AND REGULATION OF PLASMA FOR FRACTIONATION |
| A. Padilla (World Health Organization, Geneve,
Switzerland) |
| 11.30 - 11.50 |
| 4PS-18-04
CLINICAL OUTCOMES FROM THE EVOLUTION IN
QUALITY OF PLASMA-DERIVED PRODUCTS |
| C. Dash (Sanquin, Amsterdam, Netherlands) |
| 11.50 - 12.00 |
| DISCUSSION TIME |
| |
| 10.30 - 12.00 |
Auditorium |
| S19: Donor Management - Recruiting and Managing
Donors |
| Chairs: G.M. Thurtell, S. Daigneault |
| 10.30 - 10.55 |
| 4PS-19-01 BUILDING DONOR LOYALTY |
| P.V. Holland (University of California, Davis Medical Center,
Sacramento, United States of America) |
| 10.55 - 11.15 |
| 4PS-19-02 THE DONATION EXPERIENCE: TURNING DATA INTO SUCCESS |
|
S. Daigneault (Hema-Quebec, Saint Laurent, Canada)
|
| 11.15 - 11.30 |
| 4PS-19-03
EXPERIENCE WITH SCREENING VOLUNTEER BLOOD DONORS FOR
CARDIOVASCULAR DISEASE RISK. AN INNOVATIVE APPROACH TO MOTIVATION
AND HEALTH AWARENESS. |
| M.H. Sayers, J. Centilli, S. Eason, S. Myers, S. Goudar (Carter
BloodCare, Bedford, United States of America) |
| 11.30 - 11.45 |
| 4PS-19-04
AVOIDING 'MARKETING MYOPIA' IN VOLUNTARY BLOOD
DONATION (WHAT IS WRONG WITH THE PROMOTION OF VOLUNTARY BLOOD
DONATION?) |
| I.B. Petrovic (University of Belgrade, Beograd, Serbia and
Montenegro) |
| 11.45 - 12.00 |
| 4PS-19-05
THIRD PARTY INFORMATION,SUBJECTIVE DONOR ASSESSMENT
AND SEROCONVERSION RATES IN BLOOD DONORS |
| V. Poovalingam, R. Patak, P. Knox (South African National Blood
Service, Durban, South Africa) |
| |
| 10.30 - 12.00 |
Ballroom East |
| S20: Transfusion Transmitted Diseases (TTD) |
| Chairs: R. Dodd, S. Wendel |
| 10.30 - 11.00 |
| 4PS-20-01 TRANSFUSION TRANSMITTED AMERICAN AND AFRICAN
TRYPANOSOMIASIS (CHAGAS DISEASE AND SLEEPING SICKNESS): NEGLECTED OR
REALITY? |
| S. Wendel (Hospital Sírio Libanes, Sao Paulo, Brazil) |
| 11.00 - 11.30 |
| 4PS-20-02 TTD POTPOURI |
| D. Leiby (American Red Cross, Rockville, United States of
America) |
| 11.30 - 12.00 |
| 4PS-20-03 PRESENT AND FUTURE CONCERNS OVER VARIANT CJD |
| J. Ironside (University of Edinburgh, Edinburgh, United Kingdom) |
| |
| 12.00 – 14.00 |
| LUNCH BREAK, VISIT TO THE EXHIBITION AND
POSTERS AND SATELLITE SYMPOSIA |
| |
| SATELLITE SYMPOSIA |
12.15 – 13.45
Satellite Symposium organised by Roche Molecular Systems |
Room 1.41 – 1.44 |
| Perspectives on Approaches for NAT Automation |
| NAT AND BLOOD SCREENING |
| J. Saldanha (Roche Molecular Systems,
Pleasanton, United States of America) |
| COMPARATIVE EVALUATION OF AUTOMATED NAT SYSTEMS: COBAS S 201 SYSTEM (ROCHE) AND TIGRIS SYSTEM (CHIRON) |
| |
| WORKFLOW STUDY: EFS EVALUATION OF COBAS S 201 SYSTEM (ROCHE) AND TIGRIS SYSTEM (CHIRON) |
| V. Barlet (EFS Centre Atlantique, Tours, France) |
| COBAS S 201 SYSTEM: AUTOMATED BLOOD SCREENING PLATFORM |
| L. Jarvis (SNBTS, Edinburgh, United Kingdom) |
| COBAS S 201 BLOOD SCREENING SYSTEM |
| |
12.15 – 13.45
Satellite Symposium organised by BioRad |
Ballroom West |
| Performance and Cost-Efficiency of HIV and HCV Combo Simultaneous Antigen and Antibody Detection: A Affordable Alternative to N.A.T. in Blood Bank? |
| DETECTION OF HCV AG/AB : A VIABLE
ALTERNATIVE TO NAT? |
| A. Kitchen (Head, National TM
Reference Laboratory, United Kingdom) |
| SPECIFICITY STUDY OF THE NEW
GENSCREEN ULTRA HIV AG-AB COMBO ASSAY IN BLOOD BANK ROUTINE TESTING |
| T. Levayer (Etablissement Français du
Sang, Montpellier, France) |
| SENSITIVITY STUDY OF NEW GENERATION
HIV AG-AB COMBO ASSAYS REGARDING NAT AND HIV ANTIGEN DETECTIONS |
| T.D. Ly (Laboratoire Claude Levy, Ivry
sur Seine, France) |
| COST-EFFECTIVENESS OF SCREENING
STRATEGIES IN ADDITION TO ANTIBODY SCREENING FOR HIV AND HCV IN
GHANA, THAILAND AND THE NETHERLANDS |
| M. van Hulst (PharmD, University
Center for Pharmacy, Groningen, Netherlands) |
| WEB-BASED HEALTH ECONOMICS TOOLKIT
FOR BLOOD BANK SCREENING TO SUPPORT POLICY DECISIONS |
| G.A.A. Hubben (MSC, REMEDA, Groningen,
Netherlands) |
| CLOSING THE WINDOW : NAT VERSUS AG/AB |
| J. Barbara (University of West
England, United Kingdom) |
| |
| PARALLEL SESSIONS |
| 14.00 - 15.30 |
Ballroom West |
| S21: Haemostasis |
| Chairs: J. Mahlangu, E. Tuddenham |
| 14.00 - 14.30 |
| 4PS-21-01 R VIIA FOR NON-HAEMOPHILIACS; HELP OR HYPE - A CRITICAL REVIEW OF OFF-LABEL USE OF R VIIA |
| S. Dzik (Brookline, Mass, United States of America) |
| 14.30 - 15.00 |
| 4PS-21-02 GENE THERAPY FOR HAEMOPHILIA: THE PROS AND CONS |
| E. Tuddenham, P. Giangrande (United Kingdom) |
| 15.00 - 15.15 |
| 4PS-21-03
REDUCED APC CATALYZED INACTIVATION OF FACTOR VA BOUND TO STORAGE INDUCED MICROPARTICLES |
| E.J.P. Magdeleyns, J.F.W. Keuren, C. Van der Zwaan, S. Meijer,
J. Curvers (Sanquin Blood Bank Southeast region, Maastricht, Netherlands) |
| 15.15 - 15.30 |
| 4PS-21-04
CLINICAL EVALUATION OF FIBRIN SEALANT PRODUCED BY CRYOSEAL® FS SYSTEM IN PATIENTS UNDERGOING LIVER RESECTION: A MULTICENTER RANDOMIZED CLINICAL TRIAL |
| V. Kumar, T. Madsen, C. Weatherford, V. Kumar, J. Chapman
(University of Miami School of Medicine, Miami, United States of America) |
| |
| 14.00 - 15.30 |
Room: 1.61 - 1.64 |
| S22: Artificial O2 Carriers: Status 2006 |
| Chairs: E. Briët, N. Novitsky |
| 14.00 - 14.30 |
| 4PS-22-01OVERVIEW OF ARTIFICIAL O2 CARRIERS |
| A. Pape (Johann Wolfgang Goethe - University, Frankfurt Am Main,
Germany) |
| 14.30 - 15.00 |
| 4PS-22-02 HEMOSPAN®: SCIENTIFIC FOUNDATIONS AND CLINICAL DEVELOPMENT |
| B. Winslow (Sangart Inc., San Diego, United States of America) |
| 15.00 - 15:30 |
| 4PS-22-03
BOVINE HEMOGLOBIN (HEMOPURE): CLINICAL USE IN SOUTH AFRICA |
| L.J. Levien (Milpark Hospital, Johannesburg, South Africa) |
| |
| 14.00 - 15:30 |
Auditorium |
| S23: HIV |
| Chairs: R.M. Wood, M.P. Busch |
| 14.00 - 14:30 |
| 4PS-23-01 HAEMATOLOGICAL MANIFESTATIONS OF HIV IN PAEDIATRIC PRACTICE AND TRANSFUSION MANAGEMENT OF HIV |
| G. Gray (Perinatal HIV Research Unit, University of the
Witwatersrand, Diepkloof, South Africa) |
| 14:30 - 15.00 |
| 4PS-23-02 BIOLOGY OF HIV IN AFRICA |
| C. Williamson (HDMM, University of Cape Town, Cape Town, South
Africa) |
| 15.00 - 15:15 |
| 4PS-23-03
GENITAL HERPES (HSV-2) EXPOSURE CORRELATES STRONGLY WITH PREVALENT HIV-1 INFECTIONS IN SOUTH AFRICAN BLOOD DONORS: A PILOT STUDY |
| R.J. Benjamin, C.T. Fang, A. Puren, B.D. Schoub, M. Vermeulen,
C. Coleman, A. du P. Heyns, R.L. Crookes (American Red Cross Blood Services, Dedham, United
States of America) |
| 15:15 - 15:30 |
| 4PS-23-04
PK BLOOD GROUP ANTIGEN: A NATURAL RESISTANCE FACTOR TO HIV INFECTION |
| N. Lund, D. Sakac, C.A. Lingwood, C. Levene, A. Hellberg, M.L.
Olsson, D.R. Branch (University of Toronto, Toronto, Canada) |
| |
| 14.00 - 15.30 |
Room: 1.41 - 1.44 |
| S24: An Update on Blood Transfusion Services/Practice in Africa |
| Chairs: J. Emmanuel, J.B. Tapko |
| 14.00 - 14.05 |
| WELCOME AND INTRODUCTION OF AFSBT PRSIDENT |
| J. Emmanuel (Malawi Blood Transfusion Service Project, Malawi) |
| 14.05 - 14.10 |
| PRESIDENTIAL ADDRESS |
| K. Bouhef (National Blood Transfusion Service, Tunis, Tunisia) |
| 14.10 - 14.19 |
| 4PS-24-01 CURRENT STATUS OF THE BLOOD PROGRAMME IN NAMIBIA: IMPROVING BLOOD SAFETY AND ADEQUACY AND FUTURE CHALLENGES |
| R. Redeker, R. Wilkinson (Blood Transfusion Service, Namibia) |
| 14.19 - 14.28 |
| 4PS-24-02 NIGERIA: EMERGENCE OF THE RUDIMENTS OF CENTRALIZED, NATIONALLY-COORDINATED BLOOD SERVICE - THE GOALS, SUCCESSES, CHALLENGES AND FUTURE PLANS |
| F. Ayo (Federal Ministry of Health Nigeria, Abuja, Nigeria) |
| 14.28 - 14.37 |
| 4PS-24-03
THE CONCEPT TO PROVISION OF SAFE BLOOD IN A DEVELOPING COUNTRY: THE LAGOS STATE MODEL |
| R. Olatunji (Lagos State Health Service Commission, Lagos,
Nigeria) |
| 14.37 - 14.46 |
| 4PS-24-04
ANTI - U IDENTIFIED IN ERITREA |
| G. Williams (National Health Laboratory, Asmara, Eritrea) |
| 14.46 - 14.55 |
| 4PS-24-05
QUALITY MANAGEMENT IN THE WHO AFRO - ANGLOPHONE REGION |
| N. Rosin (South African National Blood Service (SANBS),
Roodepoort, South Africa) |
| 14.55 - 15.04 |
| 4PS-24-06
A RAPID SCALE UP OF THE BLOOD TRANSFUSION PROGRAMME IN ZAMBIA |
| K. Muyinda, K. Mulenga, N. Chikwese (Zambia National Blood
Transfusion Servic, Lusaka, Zambia) |
| 15.04 - 15.13 |
| 4PS-24-07
CURRENT STATE OF BLOOD COLLECTION AND TRANSFUSION IN KENYA |
| J. Mwangi, J.A. Nyamongo, L.H. Marum (Centers for Disease
Control and Preventi, Nairobi, Kenya) |
| 15.13 - 15.22 |
| 4PS-24-08 BLOOD TRANSFUSION IN BURKINO FASO: EXPERIENCE OF BOBO DIOULASSO BLOOD TRANSFUSION CENTRE |
| H. Dahourou (Centre Régional de Transfusion Sanguine (CRTS),
Bobo-Droulasso, Borbina, Fasso) |
| 15.22 - 15.30 |
| GENERAL DISCUSSION AND CLOSURE |
| J. Emmanuel (Malawi Blood Transfusion Service Project, Malawi) |
| |
| 14.00 - 15.30 |
Ballroom East |
| S25: Donor Management |
| Chairs: V. Poovalingam, D. Teo |
| 14.00 - 14.25 |
| 4PS-25-01 COUNSELLING THE HIV AND HEPATITIS POSITIVE DONOR |
| C. Sims (Western Province Blood Transfusion Service, Howard
Place, South Africa) |
| 14.25 - 14.45 |
| 4PS-25-02 IMPACT OF ADVERSE DONOR REACTIONS ON BLOOD CENTRES AND THE DONOR |
| J. Jørgensen (Blood Transfusion Center,
Aarhus, Denmark) |
| 14.45 - 15.00 |
| 4PS-25-03
ANALYSIS OF COMPLAINTS RECEIVED BY THE UK BLOOD SERVICES CONCERNING THE POLICY BARRING HOMOSEXUAL MEN FROM DONATING BLOOD |
| F. Boulton, S. Curtis (National Blood Service England,
Southampton, United Kingdom) |
| 15.00 - 15.15 |
| 4PS-25-04
DEVELOPMENT OF A WORKBOOK TO INCLUDE COMPETENCY ASSESSMENTS FOR USE IN INTRA-OPERATIVE CELL SALVAGE TRAINING |
| J. Jones, C.A. Howell (Welsh Blood Service, Cardiff, United
Kingdom) |
| 15.15 - 15.30 |
| 4PS-25-05
APPLICATION AND EVALUATION OF POLYMERASE CHAIN REACTION (PCR) IN DETECTION OF MALARIA INFECTION IN DONORS OF TRANSFUSION CENTERS IN SISTAN -BALOOCHESTAN PROVINCE |
| M. Moghtadaei, S. Amini kafiabad, G. Edrissian, S. Samiei (Iranian
Blood Transfusion ORG.research, Tehran, Iran) |
| |
| 15.30 – 16.00 |
| TEA BREAK |
| |
| 16.00 - 17.30 |
Ballroom West |
| S26: Role of International Organisations in
Strengthening/Supporting Blood Transfusion Services |
| Chairs: K. Boukef, P.F.W. Strengers |
| 16.00 - 16.20 |
| 4PS-26-01 WHO INITIATIVES |
| N. Dhingra (WHO, Geneve, Switzerland) |
| 16.20 - 16.40 |
| 4PS-26-02 CDC INITIATIVES - PEPFAR (PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF) |
| L. Marum (Centres for Disease Control and Prevention, Nairobi,
Kenya) |
| 16.40 - 17.00 |
| 4PS-26-03 ISBT |
| P.F.W. Strengers (Secretary General ISBT) |
| 17.00 - 17.20 |
| 4PS-26-04 ADRP |
| S. Churchill (Mayo Clinic Blood Donor Program, Rochester, United
States of America) |
| 17.20 - 17.30 |
| 4PS-26-05 ALLIANCE OF BLOOD OPERATORS:
Global performance improvement through benchmarking |
| S. Morgen (NHSBT International, Bristol, United Kingdom) |
| |
| 16.00 - 17.30 |
Room 1.41 - 1.44 |
| S27: Resuscitation/Massive Transfusion |
| Chairs: M. James, E. Steyn |
| 16.00 - 16.30 |
| 4PS-27-01 RECENT ADVANCES IN TRAUMA SURGERY |
| A. Nichol (Groote Schuur Hospital, Cape Town, South Africa) |
| 16.30 - 17.00 |
| 4PS-27-02 DAMAGE CONTROL SURGERY |
| E. Steyn (Christiaan Barnard Memorial Hospital, Cape Town, South
Africa) |
| 17.00 - 17.30 |
| 4PS-27-03 MASSIVE TRANSFUSION IN TRAUMA PATIENTS |
| T. Hardcastle (University of Stellenbosch, Cape Town, South
Africa) |
| |
| 16.00 - 17.30 |
Auditorium |
| S28: Nucleic Acid Amplification Testing (NAT) |
| Chairs: S. Kleinman, N. Lelie |
| 16.00 - 16.25 |
| 4PS-28-01 APPLICATION OF NUCLEIC ACID AMPLIFICATION TESTS TO STUDY TRANSFUSION-ASSOCIATED MICROCHIMERISM – A NEW COMPLICATION OF BLOOD TRANSFUSIONS IN TRAUMA PATIENTS |
| M.P. Busch (Blood Systems Research Institute, San Francisco,
United States of America) |
| 16.25 - 16.45 |
| 4PS-28-02 IMPACT OF NAT ON SEROLOGICAL SCREENING OF TTD |
| S.L. Stramer (America Red Cross, Gaithersburg, United States of
America |
| 16.45 - 17.05 |
| 4PS-28-03 NAT TESTING OF BLOOD RECIPIENTS TO PROSPECTIVELY MONITOR TRANSFUSION ASSOCIATED INFECTIONS |
| H. Alter (National Institute of Health, Bethesda, United States
of America) |
| 17.05 - 17.30 |
| 4PS-28-04 THE IMPACT OF INDIVIDUAL DONOR NAT SCREENING ON BLOOD SAFETY - THE SOUTH AFRICAN EXPERIENCE |
| A. Heyns (South African National Blood Service, Johannesburg,
South Africa) |
| |
| 16.00 - 17.30 |
Ballroom East |
| S29: Haemovigilance Systems |
| Chairs: R. de Vries, S. Asmal |
| 16.00 - 16.30 |
| 4PS-29-01 HAEMOVIGILANCE SYSTEMS: AN OVERVIEW AND USE OF DATA FOR EVALUATION |
| P. Robillard (Quebec Public Health Institute, Montreal, Canada) |
| 16.30 - 16.45 |
| 4PS-29-02
SURVIVAL AFTER BLOOD TRANSFUSION - A STUDY OF MORE THAN ONE MILLION TRANSFUSION RECIPIENTS |
| K. Titlestad, M. Ahlgren, H. Hjalgrim, K. Rostgaard Petersen, A.
Shanwell, G. Edgren, E. Tynell, R. Norda (Department of Clinical Immunology, Odense
C, Denmark) |
| 16.45 - 17.00 |
| 4PS-29-03
POTENTIAL BENEFITS OF AN INFORMATION MANAGEMENT SYSTEM TO MONITOR HEMOVIGILANCE |
| J.G. van der Wijst, A.G. van den Bos, B. de Pauw (University
Hospital St Radboud, Nijmegen, Netherlands) |
| 17.00 - 17.15 |
| 4PS-29-04
HAEMOVIGILANCE IN FRANCE: CONTRIBUTION TO THE IMPROVEMENT OF TRANSFUSION PROCESS AND PRACTICE |
| C. Caldani, N. Ounnoughene, M.P. Vo Mai, K. Martiniere, B.
Willaert, J.F. Legras, P. Zorzi (AFSSaPS, Saint-Denis, France) |
| 17.15 - 17.30 |
| 4PS-29-05
THREE YEAR TRENDS IN TRANSFUSION ASSOCIATED ADVERSE EVENTS IN CANADA, 2002-2004 |
| S Leduc, P. Robillard, N. McCombie, J. Egan, M. Cator (Public
Health Agency of Canada, Ottawa, Canada) |
| |
| 16.00 - 17.30 |
Room 1.61 - 1.64 |
| S30: Rare Donor Programme |
| Chairs: S. Nance, E. Smart |
| 16.00 - 16.20 |
| 4PS-30-01 THE INTERNATIONAL RARE DONOR PANEL |
| J. Poole (IBGRL, NBS, Bristol, United Kingdom) |
| 16.20 - 16.35 |
| 4PS-30-02 SOUTH AFRICAN RARE DONOR PANEL |
| E. Smart (South African National Blood Service, Pinetown, South
Africa) |
| 16.35 - 16.50 |
| 4PS-30-03 TESTING FOR RARE BLOOD DONORS FOR DNA ANALYSIS |
| C. Lomas-Francis (New York Blood Center, New York, United States
of America) |
| 16.50 - 17.05 |
| 4PS-30-04 THE AMERICAN RARE DONOR PROGRAM – A COLLABORATIVE PROGRAM OF THE AMERICAN RED CROSS AND THE AABB |
| S. Nance (American Red Cross, Philadelphia, United States of
America) |
| 17.05 - 17.20 |
| 4PS-30-05
SCREENING FOR BLOOD DONORS WITH RARE PHENOTYPES BY MULTIPLEX PCR WITHOUT DNA PURIFICATION |
| F. Wagner, R. Bittner, A. Döscher, E.K. Petershofen (DRK
Blutspendedienst NSTOB, Springe, Germany) |
| 17.20 - 17.35 |
| 4PS-30-06
RARE BLOOD PROGRAMME IN CHINA |
| Z. Zhu (Shanghai Blood Center, Shanghai, China) |
| |
| POSTER 2 |
| Posterwalks are going to be held for the first time this year.
This new event is introduced in order to gain a maximum benefit from the scientific work
presented and to create a lively interaction between poster authors,
moderators and interested congress participants. Posterwalks will be organised during the
poster sessions on Monday, 4 September and on Wednesday, 6 September (17.30 –
18.30 hours). The poster area is located next to the exhibtion. Poster authors, moderators and interested congress participants
are kindly requested to be present at the first poster in their poster session at the
beginning of the presentation time (17.30 hours). Snacks and drinks will be served. |
| |
THE FOLLOWING POSTERS WILL BE DISCUSSED ON WEDNESDAY:
| Topic 01.1. |
Blood Safety - TTD - HIV |
P-013 – P-024 |
| Topic 01.2. |
Blood Safety - TTD - Hepatitis |
P-056 – P-085 |
| Topic 01.4. |
Blood Safety - TTD - West Nile Virus |
P-095 – P-099 |
| Topic 01.5. |
Blood Safety - TTD - Emerging Pathogens |
P-114 – P-140 |
| Topic 01.7. |
Blood Safety - TTD - Bacterial Contamination |
P-150 – P159 |
| Topic 02.1. |
Red Cells – Immunohaematology |
P-232 – P-283 |
| Topic 02.2. |
Red Cells - Immune Haemolytic Aneamias |
P-284 – P-301 |
| Topic 02.4. |
Red Cells Transfusion |
P-327 – P-348a |
| Topic 03.2. |
Haemostatis - Related to Blood Transfusion |
| | |
